Delivery Order SPE2DB20D3101-SPE2DB25FRWC3
- Not listed
- The Defense Logistics Agency awarded a $2,731.83 delivery order to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, with an ultimate completion date of June 20, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.71 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, a pharmaceutical product used to treat Helicobacter pylori infections. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This award is a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.05 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120S, a pharmaceutical product, with an ultimate completion date of August 14, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency's Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Pylera Capsule UU 120s, a combination antibiotic medication used to treat Helicobacter pylori infections. The contract is valued at $2,266.10 under a firm fixed-price arrangement, with an ultimate completion date of April 25, 2025. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of PYLERA CAPSULE UU 120S, a pharmaceutical product, with a ceiling value of $2,736.99 and a completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $9,735.52 to AmerisourceBergen Drug Corp for 16,000 unit capsules of Pertzye DR 100s on July 24, 2025, with completion expected by July 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement for federal medical needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,324.08 to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, issued without set-aside restrictions, represents a competitively awarded contract for pharmaceutical products and medical supplies supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pirfenidone 267 mg capsules (270-count units) with a ceiling value of $5,487.30. This competitive, non-set-aside delivery order operates under a firm fixed price structure with an ultimate completion date of July 15, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a $13,920.91 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This contract utilizes firm fixed price terms with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order represents a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for typhoid polysaccharide syrup with a ceiling value of $2,055.65. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 11, 2025, and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWC3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,543.90 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, a pharmaceutical product used in bacterial infection treatment. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this firm fixed-price delivery order. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems worldwide. The DLA Troop Support Medical Supply Chain regularly utilizes this contract vehicle to fulfill pharmaceutical procurement needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.